ArticleAnnals of medicine and surgery (2012)2025

FDA approves Journavx (Suzetrigine) as the first non-opioid treatment for moderate to severe acute pain.

Muhammad Bilal Aamir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.